Regulatory T cells as a new therapeutic target for atherosclerosis.

about

Regulatory T cells as a new therapeutic target for atherosclerosis.

Item

http://www.wikidata.org/entity/Q50093330

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Regulatory T cells as a new therapeutic target for atherosclerosis.

@en

Regulatory T cells as a new therapeutic target for atherosclerosis.

@nl

type

Item

label

Regulatory T cells as a new therapeutic target for atherosclerosis.

@en

Regulatory T cells as a new therapeutic target for atherosclerosis.

@nl

prefLabel

Regulatory T cells as a new therapeutic target for atherosclerosis.

@en

Regulatory T cells as a new therapeutic target for atherosclerosis.

@nl

P1476

Regulatory T cells as a new therapeutic target for atherosclerosis

@en

P2093

Bing-Bing Guo

http://www.w3.org/2001/XMLSchema#string

Han-Xiao Ou

http://www.w3.org/2001/XMLSchema#string

Qi Liu

http://www.w3.org/2001/XMLSchema#string

Wen-Jie Feng

http://www.w3.org/2001/XMLSchema#string

Yu-Kun Li

http://www.w3.org/2001/XMLSchema#string

Zhen Yang

http://www.w3.org/2001/XMLSchema#string

Zhong-Cheng Mo

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting T cells to treat atherosclerosis: odyssey from bench to bedside

Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation

The role of T and B cells in human atherosclerosis and atherothrombosis

Subsets of regulatory T cells and their roles in allergy

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response.

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

Ibrolipim increases ABCA1/G1 expression by the LXRα signaling pathway in THP-1 macrophage-derived foam cells.

Dendritic cells in atherosclerotic disease.

P2888

aps.2017.140

P304

1249-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2017.140

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29323337

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

6289392

http://www.w3.org/2001/XMLSchema#string